Production (Stage)
AVITA Medical, Inc.
RCEL
$6.28
-$0.12-1.88%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 18.51M | 18.41M | 19.55M | 15.20M | 11.10M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 18.51M | 18.41M | 19.55M | 15.20M | 11.10M |
| Cost of Revenue | 2.83M | 2.28M | 3.19M | 2.11M | 1.51M |
| Gross Profit | 15.68M | 16.13M | 16.36M | 13.08M | 9.59M |
| SG&A Expenses | 21.22M | 21.23M | 24.73M | 23.80M | 21.60M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 30.34M | 28.36M | 33.35M | 30.80M | 28.31M |
| Operating Income | -11.83M | -9.96M | -13.81M | -15.60M | -17.21M |
| Income Before Tax | -13.85M | -11.57M | -16.23M | -15.36M | -18.63M |
| Income Tax Expenses | 8.00K | 19.00K | -28.00K | 33.00K | 30.00K |
| Earnings from Continuing Operations | -13.86M | -11.59M | -16.21M | -15.39M | -18.66M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -13.86M | -11.59M | -16.21M | -15.39M | -18.66M |
| EBIT | -11.83M | -9.96M | -13.81M | -15.60M | -17.21M |
| EBITDA | -11.31M | -9.55M | -13.50M | -15.40M | -17.00M |
| EPS Basic | -0.53 | -0.44 | -0.62 | -0.60 | -0.73 |
| Normalized Basic EPS | -0.33 | -0.28 | -0.37 | -0.37 | -0.45 |
| EPS Diluted | -0.53 | -0.44 | -0.62 | -0.60 | -0.73 |
| Normalized Diluted EPS | -0.33 | -0.28 | -0.37 | -0.37 | -0.45 |
| Average Basic Shares Outstanding | 26.25M | 26.15M | 25.98M | 25.76M | 25.64M |
| Average Diluted Shares Outstanding | 26.25M | 26.15M | 25.98M | 25.76M | 25.64M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |